Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Rhonda Naus

Physician Assistant, Medical Ft Sam Houston, TX Physician Assistant

NPI 1437149309 CMS profile 11207481

3851 Roger Brooke Dr, Brooke Army Medical Center McHe-Qdcredentials, Ft Sam Houston, TX 78234

Open in the dashboard

General payments

$39,509

216 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rhonda Naus of Ft Sam Houston, TX is reported in the CMS Open Payments database as having received $39,509 across 216 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,183 110
2024 General $13,701 49
2023 General $3,570 17
2022 General $2,624 31
2021 General $432 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rhonda Naus
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Rhonda Naus were reported at $19,183. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Rhonda Naus Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $432 $156 $41–$563 $132
2022 $2,624 $185 $55–$649 $149
2023 $3,570 $199 $58–$717 $160
2024 $13,701 $206 $62–$740 $164
2025 $19,183 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Otsuka America Pharmaceutical, Inc. $37,206 117 payments
  2. Teva Pharmaceuticals USA, Inc. $441 5 payments
  3. Neurocrine Biosciences, Inc. $344 37 payments
  4. Validus Pharmaceuticals LLC $338 3 payments
  5. Axsome Therapeutics, Inc. $250 4 payments
  6. AbbVie, Inc. $208 12 payments
  7. Supernus Pharmaceuticals, Inc. $182 14 payments
  8. E.R. Squibb & Sons, L.L.C. $148 4 payments
  9. Janssen Pharmaceuticals, Inc $80 5 payments
  10. Alkermes, Inc. $70 3 payments
  11. Other $242 12 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,506 40 payments
  2. Travel and Lodging $3,612 41 payments
  3. Food and Beverage $3,181 133 payments
  4. Education $210 2 payments
Products named General payments · program years 2021–2025
  1. REXULTI $37,245 119 payments
  2. Equetro $338 3 payments
  3. INGREZZA $298 35 payments
  4. Auvelity $250 4 payments
  5. Austedo XR $210 2 payments
  6. QELBREE $182 14 payments
  7. COBENFY $148 4 payments
  8. VRAYLAR Neuroscience $112 6 payments
  9. VRAYLAR Neuroscience $96 6 payments
  10. LYBALVI $70 3 payments
  11. Other $607 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

354

Median for Physician Assistant: 241

Drug cost

$6,595

Median for Physician Assistant: $4,110

Branded share of claims

18.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Aripiprazole Generic 15 $2,222
Quetiapine Fumarate Generic 81 $1,218
Fluoxetine Hcl Generic 51 $620
Desvenlafaxine Succinate Er Desvenlafaxine Succinate Brand 17 $496
Trazodone Hcl Generic 39 $392
Duloxetine Hcl Generic 26 $363
Lamotrigine Generic 26 $351
Sertraline Hcl Generic 13 $253
Bupropion Xl Bupropion Hcl Brand 27 $237
Citalopram Hbr Citalopram Hydrobromide Brand 20 $153

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
  • Otsuka America Pharmaceutical, Inc. $13,279
  • Lundbeck LLC $23
$13,302 — —
Auvelity
  • Axsome Therapeutics, Inc. $128
$128 — —
Austedo XR
  • Teva Pharmaceuticals USA, Inc. $109
$109 — —
VRAYLAR
  • AbbVie, Inc. $49
$49 — —
CAPLYTA
  • ITI, Inc. $45
$45 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

216 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record